
Ransh Pharma Private Limited
Pharmaceutical company specializing in manufacturing, buying, selling, and exporting various medical products.
Pharmaceutical company specializing in manufacturing, buying, selling, and exporting various medical products.
Ransh Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2018 (Seven years and one month 5 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.90 Cr.
The company currently has active open charges totaling ₹19.75 Cr.
Gowri Rao, Karri Rao, Narasingarao Karri, and Eight other members serve as directors at the Company.
Visakhapatnam, Andhra Pradesh, India
+91-XXXXXXXXXX
U74994AP2018PTC108036
108036
Private Limited Indian Non-Government Company
28 Mar 2018
30 Sep 2023
31 Mar 2023
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chitakana Rao ![]() | Managing Director | 19-Feb-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gowri Rao ![]() | Director | 28-Mar-2018 | Current |
Karri Rao ![]() | Director | 13-Jun-2018 | Current |
Narasingarao Karri ![]() | Director | 13-Jun-2018 | Current |
Vijaya Villuri ![]() | Director | 19-Feb-2022 | Current |
Naidu Kandregula ![]() | Director | 19-Feb-2022 | Current |
Venkata Putta ![]() | Director | 19-Feb-2022 | Current |
Ransh Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 298.34% increase. The company also saw a substantial improvement in profitability, with a 100.22% increase in profit. The company's net worth moved up by a moderate rise of 0.13%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Ransh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹19.75 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
12 Oct 2023 | Sidbi | ₹3.90 Cr | Open |
29 Apr 2023 | Others | ₹1.77 M | Open |
07 Feb 2022 | Sidbi | ₹2.18 Cr | Open |
29 Nov 2021 | Sidbi | ₹3.00 Cr | Open |
31 Jul 2020 | Sidbi | ₹5.00 M | Open |
Ransh Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ransh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ransh Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vasudha Veligatla was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 7 months 4 days .
Sreedevi Veligatla was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 7 months 4 days .
Tatini Radhakrishna was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 7 months 4 days .
Venkataramana Veligatla was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 7 months 4 days .
A charge with Sidbi amounted to Rs. 3.90 Cr with Charge ID 100792941 was registered on 12 Oct 2023.
Ransh Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Ransh Pharma Private Limited was incorporated on 28 Mar 2018.
The authorized share capital of Ransh Pharma Private Limited is ₹ 11.00 Cr and paid-up capital is ₹ 10.90 Cr.
Currently 11 directors are associated with Ransh Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ransh Pharma Private Limited is Plot No. 4N De-Notified Area - Apsez Atchutapuram Rambilli Mandal, India, Vishakhapatnam, Andhra Pradesh, 531061.
The corporate identification number (CIN) of Ransh Pharma Private Limited is U74994AP2018PTC108036 and the company number is 108036 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Ransh Pharma Private Limited has risen by 298.34%.
The financial reports for the fiscal year 2023 indicates that The net worth of Ransh Pharma Private Limited has experienced an upsurge of 0.13%.
As per the financial statements for fiscal Year 2023, The total open charges for Ransh Pharma Private Limited amount to ₹ 19.75 Cr.
The most recent Balance Sheet for Ransh Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
NV
AK
TK
AK
VV